title: Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients.
authors.forename: L J
authors.initials: LJ
authors.lastname: Garvey
authors.forename: H
authors.initials: H
authors.lastname: Pflugrad
authors.forename: A
authors.initials: A
authors.lastname: Thiyagarajan
authors.forename: V P B
authors.initials: VP
authors.lastname: Grover
authors.forename: S D
authors.initials: SD
authors.lastname: Taylor-Robinson
authors.forename: A
authors.initials: A
authors.lastname: Winston
authors.forename: David B
authors.initials: DB
authors.lastname: Clifford
authors.forename: Scott R
authors.initials: SR
authors.lastname: Evans
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use; D003071:Cognition / Q000502:physiology; D003072:Cognition Disorders / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology; D056344:Executive Function / Q000502:physiology; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D016174:Hepacivirus / Q000502:physiology; D019698:Hepatitis C, Chronic / Q000150:complications / Q000503:physiopathology* / Q000821:virology; D006801:Humans; D009483:Neuropsychological Tests; D012367:RNA, Viral / Q000032:analysis; D014779:Virus Replication
chemical_list: D019380:Anti-HIV Agents; D012367:RNA, Viral